SECURITIES AND EXCHANGE COMMISSION
              Washington, D.C.  20549

                    FORM 10-QSB
(Mark One)
[X]    QUARTERLY REPORT UNDER SECTION 13 OR 15(d)
       OF THE SECURITIES EXCHANGE ACT OF 1934

          For the quarterly period ended
                 September 30, 2002
or

[  ]   TRANSITION REPORT PURSUANT TO SECTION 13 OR
       15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
       For the transition period from  to

          Commission file number   0-29695

                 INJET CORPORATION
    Exact Name of registrant as specified in its
charter)

          CALIPER ACQUISITION CORPORATION
            (Former name of registrant)

Delaware                        52-2217568
(State or other jurisdiction    (I.R.S. Employer
 of incorporation organization) Or Identification
                                No.)

    1504 R Street, N.W., Washington, D.C. 20009
(Address of principal executive offices  (zip code)

                   202/387-5400
   (Registrant's telephone number, including area
code)

Indicate by check mark whether the registrant (1)
filed all reports required to be filed by Section
13 or 15(d) of the Securities Exchange Act of 1934
during the last 12 months (or for such shorter
period that the registrant was required to file
such reports), and (2) has been subject to such
filing requirements for the past 90 days.

Yes   X                  No

Indicate the number of shares outstanding of each
of the issuer's classes of common equity, as of the
latest practicable date.

Class             Outstanding at September 30, 2002

Common Stock,
par value $0.0001             5,000,000



                   PART I -- FINANCIAL INFORMATION

ITEM 1.  FINANCIAL STATEMENTS

                 INJET CORPORATION
           (A Development Stage Company)
              As of September 30, 2002
                    (Unaudited)
<TABLE>
<CAPTION>
                       ASSETS

<S>                               <C>
Cash                              $  2,022
                                   --------
TOTAL ASSETS                      $  2,022
                                   ========

LIABILITIES AND STOCKHOLDER'S EQUITY

LIABILITIES                       $  -
                                    -------
STOCKHOLDER'S EQUITY

Preferred Stock, $.0001 par value,
20,000,000 shares authorized,
none issued and outstanding           -
Common Stock, $.0001 par value,
100,000,000 shares authorized,
5,000,000 issued and outstanding       500
Additional paid-in capital           2,095
Deficit accumulated during
development stage                     (573)
                                    -------
Total Stockholder's Equity           2,022
                                    -------
TOTAL LIABILITIES AND
   STOCKHOLDER'S EQUITY             $2,022
                                    =======
</TABLE>

See accompanying notes to financial statements

<PAGE>
                    INJET CORPORATION
               (A Development Stage Company)
                  Statement of Operations
                        (Unaudited)
<TABLE>
<CAPTION>
             For the nine    For the nine   March 24,1999
             Months Ended    Months ended   (Inception)to
             Sept 30, 2002   Sept 30, 2001  Sept 30, 2002

<S>          <C>              <C>            <C>
Income       $    -            $  -           $  -

Expenses
  Organization
    expense         -               -            573
              ----------       --------         --------

Total expenses     -               -             573
              ----------       --------         -------
NET LOSS           -               -            (573)
               =========       ========         =======
</TABLE>

       See accompanying notes to financial statements
<PAGE>

                     INJET CORPORATION
               (A Development Stage Company)
        Statement of Changes in Stockholder's Equity
       For the Period From March 24, 1999 (Inception)
                   To September 30, 2002
                        (Unaudited)
<TABLE>
<CAPTION>
<S>                <C>         <C>        <C>          <C>            <C>
                                                       Deficit
                                                       Accumulated
                   Common Stock           Additional   During
                   Issued                 Paid-In      Development
                   Shares       Amount    Capital      Stage          Total

Common Stock
  Issuance         5,000,000    $ 500     $  -         $   -          $  500

Fair value of
expenses contributed   -           -         535           -             535

Capital Contribution   -           -       1,560           -           1,560

Net loss for the periods ended:

December 31, 1999      -           -          -           (535)         (535)
December 31, 2000      -           -          -             -            -
December 31, 2001      -           -          -            (38)          (38)
Setp. 30, 2002         -           -          -             -            -
                    -------     -------    -------      ---------     --------
BALANCE AT
Sept. 30, 2002     5,000,000     $ 500     $2,095        $ (573)       $2,022
==============     =========     ======    =======      =========     ========

</TABLE>
            See accompanying notes to financial statements
<PAGE>

                          INJET CORPORATION
                    (A Development Stage Company)
                       Statements of Cash Flows
                              Unaudited
<TABLE>
<CAPTION>
                           January 1, 2002     January 1, 2001    March 24, 1999
                           to                  to                 (Inception) to
                           Sept. 30, 2002      Sept.30, 2001      Sept. 30, 2002
<S>                        <C>                 <C>                 <C>
CASH FLOWS FROM OPERATING
    ACTIVITIES:
Net loss                    $      -             $  -                $    (573)
 Adjustment to reconcile net
 loss to net cash
 used by operating activities

 Contributed expenses              -                 -                     535
                              ----------          ------------        ----------
 Net cash used in operating
  activities                        -                 -                    (38)
                              ----------          ------------        ----------
CASH FLOWS FROM INVESTING
 ACTIVITIES                         -                 -                        -
                              ----------           ------------       ----------
CASH FLOWS FROM FINANCING  ACTIVITIES:

Proceeds from capital
  contributions                    -                   -                  1,560
Proceeds from issuance of
 common stock                       -                  -                    500
                             ----------             ------------       ----------
Net cash provided by
 financing activities               -                   -                 2,060
                             ----------             ------------       ----------
INCREASE IN CASH AND CASH
 EQUIVALENTS                        -                   -                 2,022
CASH AND CASH EQUIVALENTS
 BEGINNING OF PERIOD            2,022                  2,022                 -
                             ----------              -----------       ----------
CASH AND CASH EQUIVALENTS
  END OF PERIOD               $ 2,022                 $2,022             $2,022
                             ==========               ==========       ===========

</TABLE>
            See accompanying notes to financial statement.
<PAGE>


NOTE 1  SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

(A) Organization and Business Operations

Injet Corporation (a development stage company) (the "Company") was
incorporated in Delaware on March 24, 1999 to serve as a vehicle to effect a
merger, exchange of capital stock, asset acquisition or other business
combination with a domestic or foreign private business.  At September 30,
2002, the Company had not yet commenced any formal business operations,
and all activity to date relates to the Company's formation.  The Company's
fiscal year end is December 31.

The Company's ability to commence operations is contingent upon its ability
to identify a prospective target business.

(B) Use of Estimates

The preparation of the financial statements in conformity with generally
accepted accounting principles requires management to make estimates and
assumptions that affect the reported amounts of assets and liabilities and
disclosure of contingent assets and liabilities at the date of the financial
statements and the reported amounts of revenues and expenses during the
reporting period.  Actual results could differ from those estimates.

(C) Cash and Cash Equivalents

For purposes of the statement of cash flows, the Company considers all highly
liquid investments purchased with an original maturity of three months or less
to be cash equivalents.

(D) Income Taxes

  The Company accounts for income taxes under the Financial Accounting
  Standards Board of Financial Accounting Standards No. 109, "Accounting for
  Income Taxes" ("Statement 109"). Under Statement 109, deferred tax assets
  and liabilities are recognized for the future tax consequences attributable
  to differences between the financial statement carrying amounts of existing
  assets and liabilities and their respective tax basis. Deferred tax assets
  and liabilities are measured using enacted tax rates expected to apply to
  taxable income in the years in which those temporary differences are expected
  to be recovered or settled.  Under Statement 109, the effect on deferred tax
  assets and liabilities of a change in tax rates is recognized in income in
  the period that includes the enactment date. There were no current or
  deferred income tax expense or benefits due to the Company not having any
  material operations for the years ended December 31, 2001 and 2000.

(E) New Accounting Pronouncements

The Financial Accounting Standards Board has recently issued several new
Statements of Financial Accounting Standards.  Statement No. 141, "Business
Combinations" supersedes APB Opinion 16 and various related
pronouncements.  Pursuant to the new guidance in Statement No. 141, all
business combinations must be accounted for under the purchase method of
accounting; the pooling-of-interests method is no longer permitted.  SFAS
141 also establishes new rules concerning the recognition of goodwill and
other intangible assets arising in a purchase business combination and requires
disclosure of more information concerning a business combination in the
period in which it is completed.  This statement is generally effective for
business combinations initiated on or after July 1, 2001.

Statement No. 142, "Goodwill and Other Intangible Assets" supercedes APB
Opinion 17 and related interpretations.  Statement No. 142 establishes new
rules on accounting for the acquisition of intangible assets not acquired in a
business combination and the manner in which goodwill and all other
intangibles should be accounted for subsequent to their initial recognition in
a business combination accounted for under SFAS No. 141.  Under SFAS No.
142, intangible assets should be recorded at fair value.  Intangible assets with
finite useful lives should be amortized over such period and those with
indefinite lives should not be amortized.  All intangible assets being amortized
as well as those that are not, are both subject to review for potential
impairment under SFAS No. 121, "Accounting for the Impairment of Long-
Lived Assets and for Long-Lived Assets to be Disposed of".  SFAS No. 142
also requires that goodwill arising in a business combination should not be
amortized but is subject to impairment testing at the reporting unit level to
which the goodwill was assigned to at the date of the business combination.

SFAS No. 142 is effective for fiscal years beginning after December 15, 2001
and must be applied as of the beginning of such year to all goodwill and other
intangible assets that have already been recorded in the balance sheet as of the
first day in which SFAS No. 142 is initially applied, regardless of when such
assets were acquired.  Goodwill acquired in a business combination whose
acquisition date is on or after July 1, 2001, should not be amortized, but
should be reviewed for impairment pursuant to SFAS No. 121, even though
SFAS No. 142 has not yet been adopted.  However, previously acquired
goodwill should continue to be amortized until SFAS No. 142 is first adopted.

Statement No. 143 "Accounting for Asset Retirement Obligations" establishes
standards for the initial measurement and subsequent accounting for
obligations associated with the sale, abandonment, or other type of disposal
of long-lived tangible assets arising from the acquisition, construction, or
development and/or normal operation of such assets.  SFAS No. 143 is
effective for fiscal years beginning after June 15, 2002, with earlier
application encouraged.

The adoption of these pronouncements will not have a material effect on the
Company's financial position or results of operations.

NOTE 2      STOCKHOLDER'S EQUITY

(A) Preferred Stock

The Company is authorized to issue 20,000,000 shares of preferred stock at
$.0001 par value, with such designations, voting and other rights and
preferences as may be determined from time to time by the Board of
Directors.

(B) Common Stock

The Company is authorized to issue 100,000,000 shares of common stock at
$.0001 par value.  The Company issued 5,000,000 shares of its common stock
to TPG Capital Corporation ("TPG") pursuant to Rule 506 for an aggregate
consideration of $500.

(C) Additional Paid-In Capital

Additional paid-in capital at September 30, 2002 represents $1,560
contributed to the Company by TPG in 2001 and the fair value of the
organization and professional costs incurred by TPG on behalf of the
Company amounting to $535 in 1999 (See Note 3).

NOTE 3      AGREEMENT

On March 24, 1999, the Company signed an agreement with TPG, a related
entity (See Note 4).  The Agreement calls for TPG to provide the following
services, without reimbursement from the Company, until the Company enters
into a business combination as described in Note 1(A):

  1.   Preparation and filing of required documents with the Securities and
  Exchange Commission.
  2.   Location and review of potential target companies.
  3.   Payment of all corporate, organizational, and other costs incurred by
  the Company.

                       NOTE 4       RELATED PARTIES

Legal counsel to the Company is a firm owned by a director of the Company
who also owns a controlling interest in the outstanding stock of TPG (See
Note 3).

                       NOTE 5       CHANGE IN NAME

On January 7, 2002, in anticipation of  an acquisition of a
majority interest in a California corporation, the Company
changed its name to Injet Corporation.  No agreements were
entered into and discussions with that corporation have ended.
As of the date of this report, the Company has begun seeking
other target company candidates.



ITEM 2.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF
    FINANCIAL CONDITION AND  RESULTS OF OPERATIONS

     The Company was formed to locate and negotiate with a
business entity for the combination of that target
company with the Company.  A combination will normally
take the form of a merger, stock-for-stock exchange or
stock-for-assets exchange (the "business combination").
In most instances the target company will wish to
structure the business combination to be within the
definition of a tax-free reorganization under Section 351
or Section 368 of the Internal Revenue Code of 1986, as
amended.  No assurances can be given that the Company
will be successful in locating or negotiating with any
target business.

     The Company has not restricted its search for any
specific kind of businesses, and it may acquire a
business which is in its preliminary or development
stage, which is already in operation, or in essentially
any stage of its business life. It is impossible to
predict the status of any business in which the Company
may become engaged, in that such business may need to
seek additional capital, may desire to have its shares
publicly traded, or may seek other perceived advantages
which the Company may offer.

     In implementing a structure for a particular business
acquisition, the Company may become a party to a merger,
consolidation, reorganization, joint venture, or
licensing agreement with another corporation or entity.

     It is anticipated that any securities issued in any
such business combination would be issued in reliance
upon exemption from registration under applicable federal
and state securities laws.  In some circumstances,
however, as a negotiated element of its transaction, the
Company may agree to register all or a part of such
securities as part of the business combination or at
specified times thereafter.

     Negotiations with a target company will likely focus
on the percentage of the Company which the target company
shareholders would acquire in exchange for their
shareholdings.  Although the terms of such agreements
cannot be predicted, generally such agreements will
require certain representations and warranties of the
parties thereto, will specify certain events of default,
will detail the terms of closing and the conditions which
must be satisfied by the parties prior to and after such
closing and will include miscellaneous other terms.  Any
merger or acquisition effected by the Company can be
expected to have a significant dilutive effect on the
percentage of shares held by the Company's shareholders
at such time.

     On January 7, 2002, in anticipation of  an
acquisition of a majority interest in a California
corporation, the Company changed its name to Injet
Corporation.  No agreements were entered into and
discussions with that corporation have ended.  As of the
date of this report, the Company has begun seeking other
target company candidates.

     Pursuant to Rules adopted by the Securities and Exchange
Commission under Section 302(a) of the Sarbanes-Oxley Act of 2002,
the principal executive and financial officer of the Company has certified
the financial and other information contained in this report, has
evaluated the effectiveness of the Company's disclosure controls and
procedures within the period covered by this report, and has concluded
that such disclosure controls and procedures are effective. There have
been no significant changes in the internal controls of the Company or
other factors that could significantly affect internal controls subsequent
to the date of that evaluation.

           PART II -- OTHER INFORMATION

ITEM 1.  LEGAL PROCEEDINGS

     There are no legal proceedings against the Company and the
Company is unaware of such proceedings contemplated against it.

ITEM 2.  CHANGES IN SECURITIES

     Not applicable.

ITEM 3.  DEFAULTS UPON SENIOR SECURITIES

     Not applicable.

ITEM 4.  SUBMISSION OF MATTERS TO A VOTE OF
            SECURITY HOLDERS

     Not applicable.

ITEM 5.  OTHER INFORMATION

     Not applicable.

ITEM 6.  EXHIBITS AND REPORTS ON FORM 8-K

     (a)     Exhibits

     None

     (b)     Reports on Form 8-K

     There were no reports on Form 8-K filed by the Company during
the quarter.

SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on its
behalf by the undersigned thereunto duly authorized.

INJET CORPORATION

By:   /s/ James M. Cassidy
        President

Dated:   November 13, 2002


                  CERTIFICATION

I, James M. Cassidy, certify that:

1. I have reviewed this quarterly report on
   Form 10-QSB.

2. Based on my knowledge, this quarterly
   report does not contain any untrue
   statement of a material fact or omit to
   state a material fact necessary to make the
   statements made, in light of the
   circumstances under which such statements
   were made, not misleading with respect to
   the period covered by this quarterly
   report;

3. Based on my knowledge, the financial
   statements, and other financial information
   included in this quarterly report, fairly
   present in all material respects the
   financial condition, results of operations
   and cash flows of the registrant as of, and
   for, the periods presented in this
   quarterly report;

4. As the registrant's sole certifying
   officer, I am responsible for establishing
   and maintaining disclosure controls and
   procedures (as defined in Exchange Act
   Rules 13a-14 and 15d-14) for the registrant
   and have:

a) designed such disclosure controls and
   procedures to ensure that material
   information relating to the registrant,
   including any consolidated subsidiaries, is
   made known to me, particularly during the
   period in which this quarterly report is
   being prepared;

b) evaluated the effectiveness of the
   registrant's disclosure controls and
   procedures as of a date within 90 days
   prior to the filing of this quarterly
   report (the "Evaluation Date"); and

c) presented in this quarterly report my
   conclusion about the effectiveness of the
   disclosure controls and procedures based on
   my evaluation as of the Evaluation Date;

5.  As the registrant's sole certifying officer,
   I have disclosed, based on my most recent
   evaluation, to the registrant's auditors:

a) all significant deficiencies in the design
   or operation of internal controls which
   could adversely affect the registrant's
   ability to record, process, summarize and
   report financial data and have identified
   for the registrant's auditors any material
   weaknesses in internal controls; and

b) any fraud, whether or not material, that
   involves management or other employees who
   have a significant role in the registrant's
   internal controls.

6.  As the registrant's sole certifying
   officer, I have indicated in this quarterly
   report whether or not there were
   significant changes in internal controls or
   in other factors that could significantly
   affect internal controls subsequent to the
   date of the most recent evaluation,
   including any corrective actions with
   regard to significant deficiencies and
   material weaknesses.

Date   11/3/2002        /s/ James M. Cassidy

                        Chief Executive
                        Officer/President
                        Chief Financial Officer